JOHN R. DURANT, M.D.
This content is PDF only. Please click on the PDF icon to access.
The absurdities resulting from the application of due process to novel therapeutic endeavors in humans are strikingly illustrated by two recent events. Standing in stark contrast are the legalization of laetrile by more than 20 state legislatures and the administrative censure of one of the nation's most imaginative scientists for his attempts to use recently developed techniques of genetic engineering to cure several patients of inevitably fatal genetic disorders. In the first case, outlandish claims, presented by persons of doubtful credibility, eventually resulted in an National Institutes of Health (NIH)-funded, one-half million dollar, predictably negative clinical trial approved by four
DURANT JR. Science, Ethics, and Due Process. Ann Intern Med. 1981;95:116–117. doi: https://doi.org/10.7326/0003-4819-95-1-116
Download citation file:
Published: Ann Intern Med. 1981;95(1):116-117.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use